Anumigilimab
Modify Date: 2023-02-04 18:42:09
Anumigilimab structure
|
Common Name | Anumigilimab | ||
|---|---|---|---|---|
| CAS Number | 2416593-08-1 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of AnumigilimabAnumigilimab (CSL-324) is an humanized IgG2a mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation[1][2]. |
| Name | Anumigilimab |
|---|
| Description | Anumigilimab (CSL-324) is an humanized IgG2a mAb against human granulocyte colony-stimulating factor (G-CSF) receptor. Anumigilimab can be used for increasing numbers of neutrophils at sites of inflammation[1][2]. |
|---|---|
| Related Catalog | |
| Target |
granulocyte colony-stimulating factor (G-CSF) receptor[1] |
| References |
| No Any Chemical & Physical Properties |